| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/18/2004 | US20040054480 Three dimensional structures and models of Fc receptors and uses thereof |
| 03/18/2004 | US20040054213 Ophthalmic compositions for treating ocular hypertension |
| 03/18/2004 | US20040054193 Crystalline forms of [R-(R*,R*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid calcium salt (2:1) |
| 03/18/2004 | US20040054188 Desorption; reverse phase chromatography |
| 03/18/2004 | US20040054187 Therapeutic ureas |
| 03/18/2004 | US20040054186 Autoimmune diseases; anticancer agents; antiproliferative agents; skin disorders |
| 03/18/2004 | US20040054184 Preservative for organs, synthetic blood |
| 03/18/2004 | US20040054183 Thienopyridine derivatives, their production and use |
| 03/18/2004 | US20040054182 Antiinflammatory agents; rheumatic diseases; antiallergens; skin disorders; anticancer agents; antidiabetic agents |
| 03/18/2004 | US20040054180 Kinase inhibitors; antiinflammatory agents; respiratory system disorders; cardiovascular disorders; antidiabetic agents |
| 03/18/2004 | US20040054179 Antiallergens; skin disorders; antitumor agents; tyrosine kinase inhibitor |
| 03/18/2004 | US20040054177 Novel benzimidazole derivatives |
| 03/18/2004 | US20040054172 Oxygenated esters of 4-lodo phenylamino benzhydroxamic acids |
| 03/18/2004 | US20040054171 Polymorphic forms of a 4H-thieno[3,2-E]-1,2,4-thiadiazine 1,1-dioxide derivative |
| 03/18/2004 | US20040054167 Process for the preparation of crystalline n-formimidoyl thienamycin monohydrate (imipenem monohydrate) |
| 03/18/2004 | US20040054166 Isolation of glucan particles and uses thereof |
| 03/18/2004 | US20040054155 Oligonucleotide compositions with enhanced efficiency |
| 03/18/2004 | US20040054145 Truncated cd200 |
| 03/18/2004 | US20040054133 Multiple sclerosis-related superantigen |
| 03/18/2004 | US20040054132 Comprises fatty acid-conjugated products with disulfide linkage to proteins/peptides for delivery to cells; increases absorption and prolongs blood and tissue retention |
| 03/18/2004 | US20040054015 Gel for treatment of skin diseases |
| 03/18/2004 | US20040054014 Administering to subject at least one chemotherapeutic agent and at least one 3-aryloxy-3-phenylpropylamine; for multidrug resistance cancer |
| 03/18/2004 | US20040054013 Peptide-free N-methyl-D aspartate receptor open channel blocker which mitigates excitotoxicity to aid in preventing neuronal cell death |
| 03/18/2004 | US20040054012 Which can be utilized in injectable preparations being stable over a long period, and containing, for example, phenolic or polyphenolic substances, amino alcohols or sulphur-containing substances |
| 03/18/2004 | US20040054009 Useful for potentiating glutamate receptor function in a mammal and therefore useful for treating wide variety of conditions such as psychiatric and neurological disorders |
| 03/18/2004 | US20040054008 Administering preventively and/or therapeutically effective amount of a nonsteroidal anti-inflammatory drug such as loxoprofen |
| 03/18/2004 | US20040054007 Methods for decreasing cell proliferation based on (3r,4r)-delta8-tetrahydrocannabinol-11-oic acids |
| 03/18/2004 | US20040054006 Such as Bovine Spongiform Encephalopathy and Creutzfeldt-Jakob disease |
| 03/18/2004 | US20040054005 Sodium channel blocker compositions and the use thereof |
| 03/18/2004 | US20040054004 Dihydro-triterpenes in the treatment of viral infections, cardiovascular disease, in flammation, hypersensitivity or pain |
| 03/18/2004 | US20040054001 For preparing a pharmaceutical composition for treating diseases that may be influenced by NF-kappaB, particularly psoriasis |
| 03/18/2004 | US20040053999 Novel compounds and methods for synthesis and therapy |
| 03/18/2004 | US20040053998 For treating restenosis in tissue wherein smooth muscle cell migration occurs following angioplasty; for treatment of chronic inflammation, ischemic diseases and cancer |
| 03/18/2004 | US20040053993 Compositions of tocol-soluble therapeutics |
| 03/18/2004 | US20040053992 Methods for producing chiral chromones, chromanes, amino substituted chromanes and intermediates therefor |
| 03/18/2004 | US20040053989 Dithiolthione compounds for the treatment of neurological disorders and for memory enhancement |
| 03/18/2004 | US20040053987 Bis-heterocyclic compounds with antitumour and chemosensitising activity |
| 03/18/2004 | US20040053986 3,7-Diazabicyclo[3.3.0]octanes and their use in the treatment of cardiac arrhythmias |
| 03/18/2004 | US20040053985 Such as 1-(1-cyclooctyl-3-((nitrooxy)methyl)pyrazol-5-yl)-4-(methylsulfonyl)benzene; for synthesis of nitric oxide/ endothelium-derived relaxing factor; antiinflammatory agents; kits |
| 03/18/2004 | US20040053983 1, 2, 4-tribsubstituted benzenes as inhibitors of 15-lipoxygenase |
| 03/18/2004 | US20040053982 Such as 3-(2-(6-methyl-pyridin-2-ylamino)-5-(1,2,4)triazol-1-yl-thiazol-4 -yl)benzonitrile for treatment of inflammatory or obstrucive airways diseases |
| 03/18/2004 | US20040053981 Such as 2-(5(6)-nitro-2-benzimidazoyl)-5-(4-nitrophenyl)furan; fluorescent quantitative analysis; for treatment/prevention of cancer |
| 03/18/2004 | US20040053979 Indolyl derivatives |
| 03/18/2004 | US20040053978 Pharmaceutical compositions and methods of using C-21 modified epothilone derivatives |
| 03/18/2004 | US20040053977 Such as N-pyridin-2-yl-N'-(1-pyridin-2-yl-ethylidene)hydrazine for increasing erythropoietin levels and vascularization of tissue; antihypoxic agents |
| 03/18/2004 | US20040053975 Combinations of HMG-CoA reductase inhibitors and nicotinic acid compounds and methods for treating hypelipidemia once a day at night |
| 03/18/2004 | US20040053974 Medicinal compositions containing diuretic and insulin resistance-improving agent |
| 03/18/2004 | US20040053971 A fluorinated compounds, microbiocides, synthesis with chemical intermediates, amidation, debromination, benzylation, oximination |
| 03/18/2004 | US20040053968 Methods and compositions for treating peridontal disease |
| 03/18/2004 | US20040053967 3-(3-Amidinophenyl)-5-[({[1-(1-(iminoethyl)-4-piperidyl}amino)methyl]benzoic acid dihydrochloride and process for preparing the same |
| 03/18/2004 | US20040053965 N-type calcium channel antagonists for the treatment of pain |
| 03/18/2004 | US20040053964 N-type calcium channel antagonists for the treatment of pain |
| 03/18/2004 | US20040053963 Urotensin-II receptor antagonists |
| 03/18/2004 | US20040053962 Administering 2-(2-propyl-3-(3-(2-ethyl-4-(4-fluoropheyl)-5 -hydroxyphenoxy)propoxy)phenoxy)benzoic acid or it's derivatives, inducing cancer cells into non-cancerous cells, treating adenocarcinoma; inhibit leukotrienes binding |
| 03/18/2004 | US20040053960 Tetrahydropyridine derivatives, their preparation and their use as cell proliferation inhibitors |
| 03/18/2004 | US20040053957 Enzyme inhibitors of the I kappa B kinase, therapeutic treatment of autoimmune diseases, inflammatory diseases and cancer; chemical intermediates, sulfiding, sulfonation, desulfonation, cyclization |
| 03/18/2004 | US20040053956 Isoquinoline derivatives useful in the treatment of cns disorders |
| 03/18/2004 | US20040053955 An immunosuppressants for treating allograft rejection, transplant rejection, psoriasis, and rheumatoid arthritis, a 9,10-dihydro-9-oxo-acridine-3-yl- derivatives |
| 03/18/2004 | US20040053954 Treating bacterial infections with a 1,2,3,4-tetrahydrobeta-carbolin-2-yl-alkyl-1-one; chemical intermediates, amidation |
| 03/18/2004 | US20040053953 Treatment of chemokine mediated diseases |
| 03/18/2004 | US20040053951 Non-peptide GnRH agents, pharmaceutical compositions, and methods for their use |
| 03/18/2004 | US20040053950 Antimalarial activities and therapeutic properties of febrifugine analogues |
| 03/18/2004 | US20040053948 Isoindoledione or quinazolinedione derivatives; antiproliferative agents |
| 03/18/2004 | US20040053947 Pyrrolo[2,3-D]pyrimidine compounds |
| 03/18/2004 | US20040053946 Cancer treatment method |
| 03/18/2004 | US20040053945 Process for the preparation of a pyrazolo[4,3-d]pyrimidine derivative |
| 03/18/2004 | US20040053944 Antiprotozoa agents; 4-pyrrolidine pyrrolo(3,2-d)pyrimidine and 4-pyrrolidine pyrazolo(4,3-d)pyrimidine derivatives |
| 03/18/2004 | US20040053943 Novel compounds |
| 03/18/2004 | US20040053942 Fused pyrazole derivatives bieng protein kinase inhibitors |
| 03/18/2004 | US20040053941 Substituted pyrazine derivatives |
| 03/18/2004 | US20040053940 Interleukin 4 blockers; antiallergens |
| 03/18/2004 | US20040053939 PDE IV inhibitors to treat angiogenesis |
| 03/18/2004 | US20040053938 Administering sildenafil citrate; inhalation therapy |
| 03/18/2004 | US20040053937 Pyrimidine compounds |
| 03/18/2004 | US20040053936 Medicinal composition for oral use |
| 03/18/2004 | US20040053935 Anticancer agents |
| 03/18/2004 | US20040053934 Anticancer agents |
| 03/18/2004 | US20040053933 Ligands of melanocortin receptors and compositions and methods related thereto |
| 03/18/2004 | US20040053932 Peptide deformylase inhibtors |
| 03/18/2004 | US20040053931 Kinase inhibitors; angiogenesis inhibitors, anticancer agents, antiinflammatory agents and chronic obstructive pulmonary disease inhibitors |
| 03/18/2004 | US20040053930 7-Chloro-4-hydroxy-2-(2-pyridylethyl)-1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-dione and the use thereof for the treatment of pain |
| 03/18/2004 | US20040053929 1, 2, 5, 10-tetrahydropyridazino[4,5-b]quinoline-1,10-diones and their use for the treatment of pain |
| 03/18/2004 | US20040053928 Quinoline derivatives as antibacterials |
| 03/18/2004 | US20040053925 Novel urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and novel use |
| 03/18/2004 | US20040053924 Reacting pyrrolo(2,3-d)pyrimidin-4-one derivative containing a leaving group with a aromatic or heteroaromatic amine, hydroxy, marcaptan etc. in presence of a polar solvent and a catalyst |
| 03/18/2004 | US20040053921 Compounds useful as reversible inhibitors of cysteine proteases |
| 03/18/2004 | US20040053920 Administering to a patient suffering from caspase mediated diseses, an effective amount of a mono,bi or tri-heterocyclic ring containing nitrogen atom attached to ester or thioester to form carbamate group, as caspase inhibitor |
| 03/18/2004 | US20040053919 Administering a patient suffering from arthritic diseases, a 1,4-benzodiazapine or a 1,4-benzothiazepine derivative for treating such degenerative joint diseases |
| 03/18/2004 | US20040053918 Erythropoietin production potentiator |
| 03/18/2004 | US20040053917 Reacting cyanophenyl-4-sulfonylchloride with a piperidine-4-oxo in presence of ethylene glycol to form an intermediate, reducing cyano group, followed by amidation, then reacting with an amine to form sulfonamide end |
| 03/18/2004 | US20040053916 Cyclohexyl(alkyl)-propanolamines, preparation method and pharmaceutical compositions containing same |
| 03/18/2004 | US20040053915 Pyrazolopyridine derivatives |
| 03/18/2004 | US20040053909 Administering to a cancer patient a geldanamycin derivative containing dimethylaminoethylamine (at 17the position) group attached to the ring, for the treatment of cancer |
| 03/18/2004 | US20040053908 Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective |
| 03/18/2004 | US20040053906 Administering analogues of 2-methoxyestradiol in a therapeutic dosage form to induce apoptosis in cancerous tissues |
| 03/18/2004 | US20040053904 9-fluoro-11 beta-hydroxy-16 alpha-methyl-1,4-pregnadiene-3,20-dione 17-cyclopropanecarboxylate derivative for the treatment of respiratory system disorders such as bronchial asthma |
| 03/18/2004 | US20040053903 Method to treat cardiofibrosis with a combination therapy of an angiotensin II antagonist and an epoxy-steroidal aldosterone antagonist |
| 03/18/2004 | US20040053902 Novel composition and method for treatment of upper respiratory conditions |
| 03/18/2004 | US20040053901 A skin permeation enhancer for enhancing absorption of a steroid hormone through the skin, containing an organic solvent, a fatty (C8-C20) alcohol ester of a hydroxy acid, a lower alkyl ester of hydroxy acid and a (C6-C18) fatty acid |
| 03/18/2004 | US20040053900 Administering to a mammal a combination of cyclooxygenase-2 inhibitor and aromatase inhibitor for the prevention, or inhibition of a neoplasia, a neoplasia-related disorder, or osteoporosis in mammal in need |